PMC:7601109 / 98534-98801 JSONTXT

{"project":"LitCovid-PD-UBERON","denotations":[{"id":"T206","span":{"begin":15,"end":20},"obj":"Body_part"}],"attributes":[{"id":"A206","pred":"uberon_id","subj":"T206","obj":"http://purl.obolibrary.org/obo/UBERON_0001977"}],"text":"CAPE decreased serum creatine kinase, protein nitrotyrosine, PARP activity, MDA, leukocyte infiltration, skeletal muscle cell fragmentation and vacuolization, muscle levels of COX2, iNOS, IL-1β, MCP-1, and p65NF-κB activity to levels in resting CG1 compared with CG2."}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T885","span":{"begin":15,"end":20},"obj":"Body_part"},{"id":"T886","span":{"begin":38,"end":45},"obj":"Body_part"},{"id":"T887","span":{"begin":81,"end":90},"obj":"Body_part"},{"id":"T888","span":{"begin":105,"end":125},"obj":"Body_part"},{"id":"T889","span":{"begin":121,"end":125},"obj":"Body_part"},{"id":"T890","span":{"begin":159,"end":165},"obj":"Body_part"},{"id":"T891","span":{"begin":188,"end":192},"obj":"Body_part"},{"id":"T892","span":{"begin":188,"end":190},"obj":"Body_part"}],"attributes":[{"id":"A885","pred":"fma_id","subj":"T885","obj":"http://purl.org/sig/ont/fma/fma63083"},{"id":"A886","pred":"fma_id","subj":"T886","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A887","pred":"fma_id","subj":"T887","obj":"http://purl.org/sig/ont/fma/fma62852"},{"id":"A888","pred":"fma_id","subj":"T888","obj":"http://purl.org/sig/ont/fma/fma9727"},{"id":"A889","pred":"fma_id","subj":"T889","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A890","pred":"fma_id","subj":"T890","obj":"http://purl.org/sig/ont/fma/fma32558"},{"id":"A891","pred":"fma_id","subj":"T891","obj":"http://purl.org/sig/ont/fma/fma86583"},{"id":"A892","pred":"fma_id","subj":"T892","obj":"http://purl.org/sig/ont/fma/fma86578"}],"text":"CAPE decreased serum creatine kinase, protein nitrotyrosine, PARP activity, MDA, leukocyte infiltration, skeletal muscle cell fragmentation and vacuolization, muscle levels of COX2, iNOS, IL-1β, MCP-1, and p65NF-κB activity to levels in resting CG1 compared with CG2."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T1764","span":{"begin":66,"end":74},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T1765","span":{"begin":105,"end":125},"obj":"http://purl.obolibrary.org/obo/CL_0000188"},{"id":"T1766","span":{"begin":105,"end":125},"obj":"http://www.ebi.ac.uk/efo/EFO_0000888"},{"id":"T1767","span":{"begin":144,"end":157},"obj":"http://purl.obolibrary.org/obo/GO_0005773"},{"id":"T1768","span":{"begin":159,"end":165},"obj":"http://purl.obolibrary.org/obo/UBERON_0001630"},{"id":"T1769","span":{"begin":159,"end":165},"obj":"http://purl.obolibrary.org/obo/UBERON_0005090"},{"id":"T1770","span":{"begin":159,"end":165},"obj":"http://www.ebi.ac.uk/efo/EFO_0000801"},{"id":"T1771","span":{"begin":159,"end":165},"obj":"http://www.ebi.ac.uk/efo/EFO_0001949"},{"id":"T1772","span":{"begin":213,"end":214},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T1773","span":{"begin":215,"end":223},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"CAPE decreased serum creatine kinase, protein nitrotyrosine, PARP activity, MDA, leukocyte infiltration, skeletal muscle cell fragmentation and vacuolization, muscle levels of COX2, iNOS, IL-1β, MCP-1, and p65NF-κB activity to levels in resting CG1 compared with CG2."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T73665","span":{"begin":0,"end":4},"obj":"Chemical"},{"id":"T18752","span":{"begin":21,"end":29},"obj":"Chemical"},{"id":"T10071","span":{"begin":38,"end":45},"obj":"Chemical"},{"id":"T93390","span":{"begin":46,"end":59},"obj":"Chemical"},{"id":"T21746","span":{"begin":61,"end":65},"obj":"Chemical"},{"id":"T19656","span":{"begin":76,"end":79},"obj":"Chemical"},{"id":"T76362","span":{"begin":188,"end":190},"obj":"Chemical"},{"id":"T4833","span":{"begin":195,"end":198},"obj":"Chemical"}],"attributes":[{"id":"A32567","pred":"chebi_id","subj":"T73665","obj":"http://purl.obolibrary.org/obo/CHEBI_8062"},{"id":"A85232","pred":"chebi_id","subj":"T18752","obj":"http://purl.obolibrary.org/obo/CHEBI_16919"},{"id":"A83575","pred":"chebi_id","subj":"T18752","obj":"http://purl.obolibrary.org/obo/CHEBI_57947"},{"id":"A41442","pred":"chebi_id","subj":"T10071","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A28912","pred":"chebi_id","subj":"T93390","obj":"http://purl.obolibrary.org/obo/CHEBI_86267"},{"id":"A36830","pred":"chebi_id","subj":"T21746","obj":"http://purl.obolibrary.org/obo/CHEBI_62913"},{"id":"A46963","pred":"chebi_id","subj":"T19656","obj":"http://purl.obolibrary.org/obo/CHEBI_566274"},{"id":"A28675","pred":"chebi_id","subj":"T76362","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A9324","pred":"chebi_id","subj":"T76362","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A33681","pred":"chebi_id","subj":"T4833","obj":"http://purl.obolibrary.org/obo/CHEBI_132592"},{"id":"A36202","pred":"chebi_id","subj":"T4833","obj":"http://purl.obolibrary.org/obo/CHEBI_50099"}],"text":"CAPE decreased serum creatine kinase, protein nitrotyrosine, PARP activity, MDA, leukocyte infiltration, skeletal muscle cell fragmentation and vacuolization, muscle levels of COX2, iNOS, IL-1β, MCP-1, and p65NF-κB activity to levels in resting CG1 compared with CG2."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2853","span":{"begin":61,"end":65},"obj":"Gene"},{"id":"2854","span":{"begin":176,"end":180},"obj":"Gene"},{"id":"2855","span":{"begin":182,"end":186},"obj":"Gene"},{"id":"2856","span":{"begin":188,"end":193},"obj":"Gene"},{"id":"2857","span":{"begin":195,"end":200},"obj":"Gene"},{"id":"2858","span":{"begin":245,"end":248},"obj":"Gene"},{"id":"3018","span":{"begin":0,"end":4},"obj":"Chemical"},{"id":"3019","span":{"begin":46,"end":59},"obj":"Chemical"}],"attributes":[{"id":"A2853","pred":"tao:has_database_id","subj":"2853","obj":"Gene:11545"},{"id":"A2854","pred":"tao:has_database_id","subj":"2854","obj":"Gene:26198"},{"id":"A2855","pred":"tao:has_database_id","subj":"2855","obj":"Gene:24599"},{"id":"A2856","pred":"tao:has_database_id","subj":"2856","obj":"Gene:24493"},{"id":"A2857","pred":"tao:has_database_id","subj":"2857","obj":"Gene:24770"},{"id":"A2858","pred":"tao:has_database_id","subj":"2858","obj":"Gene:231042"},{"id":"A3018","pred":"tao:has_database_id","subj":"3018","obj":"MESH:C055494"},{"id":"A3019","pred":"tao:has_database_id","subj":"3019","obj":"MESH:C002744"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"CAPE decreased serum creatine kinase, protein nitrotyrosine, PARP activity, MDA, leukocyte infiltration, skeletal muscle cell fragmentation and vacuolization, muscle levels of COX2, iNOS, IL-1β, MCP-1, and p65NF-κB activity to levels in resting CG1 compared with CG2."}